EX-99.4 5 f8k0316ex99iv_elbit.htm TABLE OF ADVISORS RELIED UPON IN THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2015, 2014 AND 2013

 Exhibit 99.4

 

Advisors relied upon in the consolidated financial statements for the years ended December 31, 2015, 2014 and 2013

 

Exhibit No. Name of advisor  Nature of professional advice  Reference
to the
consolidated
financial
statements
            
99.5  Colliers International  Valuation of Radisson Blu Hotel and Centre Ville Apart Hotel in Bucharest, Romania as of December 31, 2013, 2014 and 2015  Note 10 C and 11F
          
99.6  Cushman & Wakefield  Valuation of Park Inn Hotel and Radison Blu Astrid Hotel in Antwerp, Belgium as of December 31, 2013 and December 31, 2014.  11F
          
99.7  Financial Immunities Dealing Room Ltd.  Valuation of options granted by PC on August 23, 2011, and November 22, 2011 under the framework of ESOP 2008 , 2011 re-pricing valuation and; March 14, 2012, May 22, 2012 , August 21, 2012 , November 20, 2012 and ESOP No.1 re-pricing valuation and, and March 13, 2013, august 22, 2013 under ESOP no.2   Note 19 B.
          
99.8  Cushman & Wakefield -  Valuation of certain trading property of PC as of December 31, 2013, 2014 and 2015.   Note 6 and 2 X (1) A
          
99.9  Giza Zinger Even  2011 re-pricing valuation of options granted by the Company for the year ended December 31 2011   
          
99.10  Giza Zinger Even  Fair value estimation of financial instrument given to the Company and by the Company to Park Plaza regarding the UK transaction, as of December 31, 2013.  Note 4A (III)
          
99.11  Giza Zinger Even  Fair value estimation of financial instrument given to the Company and by the Company to Park Plaza regarding the Dutch transaction, as of December 31, 2013.  Note 4A (III)
          
99.12  Giza Zinger Even  Valuations of options granted by the Company during the year ended December 31, 2011, under the Elbit Medical Option Plan and re-pricing valuation for the year ended December 31, 2012.  Note 19 A (2)
          
99.13  Financial Immunities Dealing Room Ltd.  Valuation of option granted by the Company during the year ended December 31, 2014 under the Elbit medical Option Plan.  Note 19A (2)
          
99.14  Greenberg Olpiner & co.  Valuation of plot located in Tiberias Israel as of December 31, 2014 and 2015.  Note 11
          
99.15  BDO Ziv Haft Consulting and Management Ltd.  Valuation of options granted by the company during the year ended December 31, 2014.  Note 19A (1)
          
99.16  Giza Zinger Even  Valuation of derivative during investment in Series D preferred share of the year ended December 31, 2014.  Note 8A
          
99.17  Variance Financials  Valuation of Gamida shares during 2014 in connection with the Novartis transaction.  Note 8B
          
99.18  Financial Immunities Dealing Room Ltd.  Fairness opinion relating effective interest of Bank Hapoalim loan for the year ended December 31, 2014.  Note 14C (1)